From Streets to Suites: How the Anti- Biotech Movement Affected German Pharmaceutical Firms

By Klaus Weber, Hayagreeva Rao, L. G. Thomas. 2009

240 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/2d4c19a32c475f8f0d3d0732d6a891cec41b4c58

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Strategy and Management

Citations in the corpus

Lords of the Harvest: Third-Party Influence and Regulatory Approval of Genetically Modified Organisms (2013, unknown): “Prior research has demonstrated that protests often attract public attention, which can in turn engage wider audiences (King & Soule, 2007; Weber, Rao, & Thomas, 2009; Ingram, Yue & Rao, 2010).”
The Behavioral Theory of the Firm: Assessment and Prospects (2012, background): “Weber, Rao, and Thomas ( 2009 ) combined coalitional perspectives with social movement theory in a study of biotechnology in German firms and find that external contestation weakened the position of internal champions of biotechnology, precipitated divisions among the dominant coalition, and undermi”
Change above the Glass Ceiling: Corporate Social Responsibility and Gender Diversity in Japanese Firms (2018, background): “…earlier studies focused primarily on how the political opportunity structure influences social movements (McAdam, 1982; Amenta, Carruthers, and Zylan, 1992), recent studies have conceptualized the opportunity structure to be in a dynamic relationship with movements (Weber, Rao, and Thomas, 2009).”
A Market Mediation Strategy: How Social Movements Seek to Change Firms’ Practices by Promoting New Principles of Product Valuation (2013, background): “The studies demonstrate that SMOs may seek to broaden their audience to increase their efficiency, either to public opinion as the anti-biotech movement did (Weber et al., 2009), or to market actors as in the case of calls for boycotts (Friedman, 1999).”
Difference in Degrees: CEO Characteristics and Firm Environmental Disclosure (2014, unknown): “Weber et al. (2009), for example, demonstrate that internal politics influence the degree to which social movement affect firm decisions.”
The Contentiousness of Markets: Politics, Social Movements, and Institutional Change in Markets (2010, background): “Weber, Rao, and Thomas (2009) show that contestation of biotechnology innovations by German pharmaceutical companies helped win allies among the professional elites of the dominant firms, which undermined the companies " commitments to the technology.”
Toward a General Theory of Strategic Action Fields* (2010, background): “…and Ekert 1986; Kurzman 1998; Lounsbury et al. 2003; McAdam and Scott 2005; McCammon 2002; Minkoff 1995; Moore and Hala 2002; Morrill et al. 2003; Rao et al. 2000, 2009; Schneiberg and Soule 2005; Smith 2002; Strang and Soule 1998; Stryker 1994; Swaminathan and Wade 2001; Weber et al. 2009).”
Asset Divestment as a Response to Media Attacks in Stigmatized Industries (2014, background): “…that pooled risk is the fact that competitors share a reputation commons (King, Lenox, and Barnett, 2002) that makes the industry cohesive as a whole (Weber et al., 2009), thereby favorably influencing customer preferences, government policy, or regulatory oversight (Fauchart and Cowan, 2014).”